Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor
CA 1340616 C · Owner: Selten, Gerardus Cornelis Maria · Inventors: Smaal, Eric Bastiaan; Slijkhuis, Herman; Selten, Gerardus Cornelis Maria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Genetically engineered host cells containing new expression cassettes are provided which are able to carry out biochemical oxidations of steroids. In particular the oxidation is carried out with cells into which DNA has been introduced which encodes protein involved in the biological pathway of cholesterol to hydrocortisone. Suited host cells comprise species of Bacillus, Saccharomyces or Kluyveromyces. The new host cells are suited for microbiological oxidations of cholesterol, pregnenolone progesterone, 17.alpha.-hydroxy-progesterone and cortexolone, which are, intermediates in said biological pathway. The new expression cassettes are also useful in the ultimate production of a multigenic …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 29, 1999. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 29, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.